Supply of NIV Drugs to Directorate of Procurement (Navy), Islamabad

The Directorate of Procurement (Navy), Islamabad, invites sealed bids from original manufacturers, authorized distributors, suppliers, and contractors registered with income tax and sales tax departments for the supply of NIV Drugs as detailed in the DP-2 form. This procurement is for the Pakistan Navy Medical Stores Depot and related medical facilities in Islamabad and Karachi. Items being procured: - Salmeterol + Fluticasone Inhaler (Adult, Infant, Paeds) 10,000 units - Cran Max Sachet or Equivalent 300,000 units - Lacosamide 100 mg Tablets/Capsules 100,000 units - Lacosamide 50 mg Tablets/Capsules 150,000 units - Eltrombopag Olamine 25 mg Tablets/Capsules 2,500 units - Eltrombopag Olamine 50 mg Tablets/Capsules 2,500 units - Tocilizumab Infusion Ampoule/Vial 4ml 25 units - Etoricoxib 60 mg Tablets 50,000 units - Etoricoxib 90 mg Tablets 20,000 units - Mirabegron 25 mg Tablets/Capsules 40,000 units - Mirabegron 50 mg Tablets/Capsules 15,000 units - Pirfenidone 200 mg Tablets/Capsules 30,000 units - Pirfenidone 267 mg Tablets/Capsules 10,000 units - Pirfenidone 801 mg Tablets/Capsules 3,000 units - Empagliflozin 10 mg Tablets/Capsules 300,000 units - Empagliflozin 25 mg Tablets/Capsules 60,000 units - Minoxidil Spray 5% 60 ml 2,000 units - Minoxidil Spray 2% 60 ml 1,200 units - Progesterone 200 mg Pessary 40,000 units - Itopride SR Tablets 100,000 units - Itopride 50 mg Tablets 400,000 units - Vitamin D 200000 IU Tablets 75,000 units - Rivaroxaban 10 mg Tablets 50,000 units - Ibandronic Acid 150 mg Tablets 2,000 units - Sodium Acid Citrate 120 ml Suspension 12,000 units - Saccharomyces Boulardii 250 mg Sachet 50,000 units - Bacillus Clausii Suspension Ampoule/Vial 5 ml 100,000 units - Febuxostat 40 mg Tablets 80,000 units - Ossein Mineral Complex + Vitamin D3 Tablets 1,800,000 units The technical scope includes supply of brand new medical drugs with minimum shelf life requirements, proper packaging, and compliance with national and international standards. Delivery is scheduled from 1st July 2027 to 30th June 2028 on a supply order basis. Inspection will be conducted by Pakistan Navy Medical Stores Depot and related authorities. Eligibility requires registration with DGDP, valid licenses, GMP and ISO certifications, and compliance with FBR Active Taxpayers List. Earnest money and bid security must be submitted as per tender conditions. Bids must be submitted in sealed envelopes containing technical and commercial offers separately, following the Single Stage - Two Envelope bidding procedure. The deadline for submission is 10 November 2026 at 1030 hours at the Directorate of Procurement (Navy), Naval Residential Complex, Sector E-8, Islamabad. Late submissions will be rejected. Bidders should ensure all documents, including treasury challan, earnest money, and technical forms, are complete and properly signed. A practical tip for bidders: Carefully follow the technical offer format and ensure all required certificates and documents are attached to avoid disqualification. Pay special attention to the shelf life and packaging requirements to meet inspection standards and avoid rejection. This tender is a significant opportunity for pharmaceutical suppliers to provide essential medicines to the Pakistan Navy under clear terms and conditions governed by PPRA Rules 2004 and DPP&I-35 (Revised 2024).